8-K: LifeStance Health Appoints Vaughn Paunovich as Chief Technology Officer; Pablo Pantaleoni to Depart

LifeStance Health announces the appointment of Vaughn Paunovich as its new Chief Technology Officer, effective June 9, 2025, while Chief Digital Officer Pablo Pantaleoni will depart on July 1, 2025.

Summary

• LifeStance Health Group, Inc. announced the appointment of Vaughn Paunovich as Chief Technology Officer, effective June 9, 2025.
• Pablo Pantaleoni, the current Chief Digital Officer, will be leaving the company on July 1, 2025.
• Paunovich will lead LifeStance's end-to-end technology strategy.
• Pantaleoni played a pivotal role in LifeStance's digital transformation since joining in 2020.
• Pantaleoni will receive separation payments and benefits, including salary continuation, COBRA premiums, and vesting of restricted stock units, subject to a release of claims and compliance with restrictive covenants.

Sentiment

Score: 7

Explanation: The announcement is generally positive, highlighting a new appointment and a planned transition. The departure of the previous executive is handled professionally with a separation agreement.

Positives

• The appointment of Vaughn Paunovich brings an experienced health care technology executive to LifeStance.
• Paunovich's background includes leading digital transformation initiatives at Amwell and UnitedHealth Group.
• The transition plan includes Pantaleoni working closely with Paunovich to ensure a seamless handover.

Negatives

• The departure of Pablo Pantaleoni, who played a pivotal role in LifeStance's digital transformation since 2020, could represent a loss of institutional knowledge.

Risks

• The transition in leadership could potentially disrupt ongoing technology initiatives.
• Ensuring a smooth transition between Pantaleoni and Paunovich is crucial to avoid any negative impact on the company's technology strategy.

Future Outlook

LifeStance aims to continue delivering a best-in-class technology experience for its patients and clinicians, increase access to services, and deliver care at scale across the country.

Management Comments

• Dave Bourdon, CEO of LifeStance, stated that Vaughn Paunovich's experience aligns perfectly with LifeStance's mission.
• Dave Bourdon believes Vaughn is the right leader to successfully execute on their long-term technology roadmap while ensuring a high-quality experience for patients and clinicians.
• Vaughn Paunovich is excited to join LifeStance and build on the organization's momentum to transform mental health care delivery.

Industry Context

The appointment of a new CTO reflects the increasing importance of technology in healthcare, particularly in mental health services, where virtual care and digital platforms are becoming more prevalent. LifeStance's focus on technology aligns with industry trends towards leveraging digital solutions to improve access to and the quality of mental healthcare.

Comparison to Industry Standards

• Amwell, where Paunovich previously worked, is a major player in the telehealth industry, providing a benchmark for digital transformation in healthcare.
• UnitedHealth Group's Optum Health, where Paunovich also held a leadership role, is known for its integrated approach to healthcare delivery, including a strong focus on technology and innovation.
• LifeStance's strategy to enhance its technology platform mirrors the efforts of other large mental health providers, such as Talkspace and Teladoc Health, which are also investing heavily in digital solutions to improve patient experience and expand access to care.

Management Changes

Stakeholder Impact

• Patients may experience improved technology and digital experiences under the new CTO's leadership.
• Clinicians may benefit from enhanced technology tools and platforms.
• Shareholders may view the appointment positively, given Paunovich's experience and the company's focus on technology.

Next Steps

• Vaughn Paunovich will assume his role as Chief Technology Officer on June 9, 2025.
• Pablo Pantaleoni will work with Paunovich to ensure a seamless transition.
• The separation agreement with Pablo Pantaleoni will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.

Key Dates

Keywords

Chief Technology Officer, LifeStance Health, Vaughn Paunovich, Pablo Pantaleoni, Appointment, Departure, Technology, Mental Health